InteliCare Completes $2m Placement to Accelerate Growth

Open PDF
Stock Intelicare Holdings Ltd (ICR.ASX)
Release Time 15 Sep 2025, 8:54 a.m.
Price Sensitive Yes
 InteliCare Completes $2m Placement to Accelerate Growth
Key Points
  • Raised $2 million via a two-tranche private placement
  • Funds will support growth strategy, accelerate deployments, and provide working capital
  • Terminated $600,000 convertible note facility to simplify capital structure
Full Summary

InteliCare Holdings Ltd (ASX: ICR), an Australian Software-as-a-Service (SaaS) technology company, has received firm commitments to raise $2 million via a two-tranche private placement to institutional and sophisticated professional investors. Under Tranche One, 121,834,000 fully paid ordinary shares will be issued immediately under the company's existing LR7.1 & 7.1A capacity, raising approximately $1.827 million. Under Tranche Two, 11,500,000 fully paid ordinary shares will be issued, subject to shareholder approvals at an upcoming EGM, raising the balance of approximately $173,000. As part of this capital raising, the $600,000 convertible note facility, entered into and announced on 9 July 2025, has been terminated with all subscribers to the facility entering into a deed of termination. The proceeds from the placement will support the company's growth strategy, allowing it to accelerate deployments for potential new customers in the pipeline and provide working capital to support pilot programs. Interim Executive Director Tim Chapman stated that the extra funds will be used to continue supporting the company's pilot with mecwacare, continued deployment at Hardi Aged Care, further enhancements to the InteliCare platform, and deliver further commercial agreements with key groups in the company's sales pipeline.

Outlook

The company is well positioned to continue delivering growth following the termination of the convertible note facility and simplification of the capital structure.